Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Inhaler
by Highest Patent Value in the China in 2019

The Inhaler top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Inhaler Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
An inhaler (also known as a puffer, pump or allergy spray) is a medical device used for delivering medication into the body via the lungs. It is mainly used in the treatment of asthma and chronic obstructive pulmonary disease. Zanamivir, used to treat influenza, must be administered via inhaler.
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 2.69 M
2
Avg patent value: 1.83 M
3
Avg patent value: 1.15 M
4
Avg patent value: 900,000
5
Avg patent value: 579,500
6
Avg patent value: 540,925
7
Medical equipment,Medicine,Nasal cannula,
...[+2]
Avg patent value: 130,000
8
Actuator,Machine element
Avg patent value: 100,000
9
Avg patent value: 76,000
10
Avg patent value: 60,000
11
Avg patent value: 57,000
12
Avg patent value: 55,000
13
Avg patent value: 53,000
14
Avg patent value: 53,000
15
Avg patent value: 52,000
16
Applied research
Avg patent value: 44,000
17
Avg patent value: 30,466
18
Avg patent value: 26,700
19
Avg patent value: 26,700
20
Avg patent value: 25,740
Page generation time: Jun 09 2025